NIAID Now

Showing results filtered by:

Clear All

Vaccine Research Center (VRC)

7 Results

How Children are Helping Scientists Battle a ‘List of Bad Viruses’

May 19, 2022

The national EV-D68 pilot study is part of PREMISE, the Pandemic Response Repository through Microbial and Immune Surveillance and Epidemiology. PREMISE is an initiative from NIAID’S Vaccine Research Center (VRC) that began in early 2021.

CDC poster showing how to prevent getting and spreading EV-D68

NIAID Scientists Advance Understanding of More Broadly Protective Flu Vaccines

May 11, 2022

NIAID researchers designed a ferritin nanoparticle flu vaccine and tested it in people with and without immunological experience of the flu virus that caused the 1957 pandemic. The experimental vaccine prompted immune responses that suggested this kind of vaccine could provide long-lasting protection against many flu subtypes.

Computer-generated image shows influenza virus hemagglutinin HA epitopes arrayed on a nanoparticle

NIAID Observes HIV Vaccine Awareness Day 2021

May 18, 2021

While implementation of highly effective HIV treatment and prevention tools has reduced the HIV pandemic worldwide, development of a safe and even modestly effective vaccine would hasten progress toward a durable end of the HIV pandemic. Today, on HIV Vaccine Awareness Day, NIAID acknowledges both the progress that has been made in HIV vaccine development and the challenges that remain. We also reflect on how advances in HIV vaccinology paved the way for COVID-19 vaccine development.